reboxetine has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM | 1 |
| Ben-Amitay, G; Laor, N; Lask, M; Ratner, S; Toren, P; Weizman, A | 1 |
1 trial(s) available for reboxetine and Body Weight
| Article | Year |
|---|---|
Reboxetine maintenance treatment in children with attention-deficit/hyperactivity disorder: a long-term follow-up study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Body Weight; Child; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Morpholines; Parents; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Suicide | 2007 |
1 other study(ies) available for reboxetine and Body Weight
| Article | Year |
|---|---|
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology | 2013 |